MRVL vs SGMT · P/E 100, rev $5.16B vs $403.2M cap
Marvell Technology Group Ltd (MRVL) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
SGMT does not have a complete income-statement cache yet.
MRVL currently screens at market cap $253.51B and trailing P/E 99.8. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the MRVL and SGMT stock pages for the full models.
Not investment advice.